AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
LSE:AZN
Price:
12 050 GBX
-0.87%
Market Closed
Updated:
May 6, 2024
AstraZeneca PLC
Total Other Income
|
AstraZeneca PLC
Total Other Income Peer Comparison
Comparables:
GSK
VRNA
INDV
HIK
DPH
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AstraZeneca PLC
LSE:AZN
|
Total Other Income
-$457m
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
0%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Total Other Income
-£48m
|
CAGR 3-Years
51%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Total Other Income
$1.1m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Total Other Income
-$8m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Total Other Income
-$14m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AstraZeneca PLC's Total Other Income?
Total Other Income
-457m
USD
-457m
USD
Based on the financial report for Dec 31, 2023, AstraZeneca PLC's Total Other Income amounts to -457m USD.
What is AstraZeneca PLC's Total Other Income growth rate?
Total Other Income CAGR 10Y
0%
0%
Over the last year, the Total Other Income growth was -4%. The average annual Total Other Income growth rates for AstraZeneca PLC have been 5% over the past three years , 6% over the past five years .
You don't have any saved screeners yet
